Loading...
XTAI
4106
Market cap74mUSD
Jul 09, Last price  
23.55TWD
1D
0.21%
1Q
5.13%
Jan 2017
-30.43%
IPO
117.05%
Name

Wellell Inc

Chart & Performance

D1W1MN
XTAI:4106 chart
P/E
19.62
P/S
0.99
EPS
1.20
Div Yield, %
3.40%
Shrs. gr., 5y
0.04%
Rev. gr., 5y
3.71%
Revenues
2.40b
+0.74%
1,577,269,0001,661,216,0001,748,518,0001,845,771,0002,016,971,0002,263,357,0002,015,894,0001,990,275,0002,089,277,0002,105,748,0002,036,232,0002,004,025,0002,374,055,0002,663,723,0002,647,122,0002,386,654,0002,404,332,000
Net income
121m
+5.11%
212,185,000180,681,000232,561,000196,220,000133,466,000178,414,000168,745,000122,504,000118,263,000108,413,00087,921,000104,588,000102,247,000161,404,000152,172,000115,239,000121,124,000
CFO
207m
-2.71%
305,286,000191,310,000285,887,000254,359,000219,054,000248,329,000277,010,000218,586,000178,212,000118,990,000173,624,000279,321,00019,005,00082,145,000455,658,000213,234,000207,452,000
Dividend
Jul 31, 20250.8 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1990 in New Taipei City, Taiwan, Wellell Inc. is a global enterprise active in the medical supplies sector. The company's activities span research and development, manufacturing, and the international distribution (import, export, and sales) of its diverse product portfolio. This includes items for wound care, respiratory therapy devices, assistive welfare equipment, and other electronic medical instruments. Wellell's specific offerings feature pressure relief mattresses and seating, as well as advanced solutions for sleep apnea, such as auto-adjusting pressure systems and their Sleepwell product line. These innovative solutions primarily focus on the prevention of pressure injuries and the management of obstructive sleep apnea.
IPO date
Jan 02, 2002
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT